Interactions of protein antigens with antibodies
- PMID: 8552677
- PMCID: PMC40169
- DOI: 10.1073/pnas.93.1.7
Interactions of protein antigens with antibodies
Abstract
There are now several crystal structures of antibody Fab fragments complexed to their protein antigens. These include Fab complexes with lysozyme, two Fab complexes with influenza virus neuraminidase, and three Fab complexes with their anti-idiotype Fabs. The pattern of binding that emerges is similar to that found with other protein-protein interactions, with good shape complementarity between the interacting surfaces and reasonable juxtapositions of polar residues so as to permit hydrogen-bond formation. Water molecules have been observed in cavities within the interface and on the periphery, where they often form bridging hydrogen bonds between antibody and antigen. For the most part the antigen is bound in the middle of the antibody combining site with most of the six complementarity-determining residues involved in binding. For the most studied antigen, lysozyme, the epitopes for four antibodies occupy approximately 45% of the accessible surface area. Some conformational changes have been observed to accompany binding in both the antibody and the antigen, although most of the information on conformational change in the latter comes from studies of complexes with small antigens.
Similar articles
-
Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).Biochemistry. 2000 May 30;39(21):6296-309. doi: 10.1021/bi000054l. Biochemistry. 2000. PMID: 10828942
-
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.J Mol Biol. 1992 Sep 5;227(1):122-48. doi: 10.1016/0022-2836(92)90687-f. J Mol Biol. 1992. PMID: 1381757
-
Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1.J Mol Biol. 1994 Nov 4;243(4):767-81. doi: 10.1016/0022-2836(94)90046-9. J Mol Biol. 1994. PMID: 7966295
-
The structural basis of antigen-antibody recognition.Annu Rev Biophys Biophys Chem. 1987;16:139-59. doi: 10.1146/annurev.bb.16.060187.001035. Annu Rev Biophys Biophys Chem. 1987. PMID: 2439094 Review.
-
The crystal structures of complexes formed between lysozyme and antibody fragments.EXS. 1996;75:301-19. doi: 10.1007/978-3-0348-9225-4_16. EXS. 1996. PMID: 8765306 Review.
Cited by
-
Computational design of a protein-based enzyme inhibitor.J Mol Biol. 2013 Sep 23;425(18):3563-75. doi: 10.1016/j.jmb.2013.06.035. Epub 2013 Jul 1. J Mol Biol. 2013. PMID: 23827138 Free PMC article.
-
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.Int J Mol Sci. 2012;13(4):5254-5277. doi: 10.3390/ijms13045254. Epub 2012 Apr 24. Int J Mol Sci. 2012. PMID: 22606042 Free PMC article. Review.
-
Antibody CDR amino acids underlying the functionality of antibody repertoires in recognizing diverse protein antigens.Sci Rep. 2022 Jul 22;12(1):12555. doi: 10.1038/s41598-022-16841-9. Sci Rep. 2022. PMID: 35869245 Free PMC article.
-
Affinity maturation of humanized anti-epidermal growth factor receptor antibody using a modified phage-based open sandwich selection method.Sci Rep. 2018 Apr 3;8(1):5414. doi: 10.1038/s41598-018-23796-3. Sci Rep. 2018. PMID: 29615700 Free PMC article.
-
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab.Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4223-E4232. doi: 10.1073/pnas.1617941114. Epub 2017 May 8. Proc Natl Acad Sci U S A. 2017. PMID: 28484017 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources